Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Not just sugar: metabolic control of neutrophil development and effector functions. | J Leukoc Biol | 2024 | 38450755 | PubTator, text mining | PubMed |
| pH regulators and their inhibitors in tumor microenvironment. | Eur J Med Chem | 2024 | 38308950 | PubTator, text mining | PubMed |
| FERM domain-containing proteins are active components of the cell nucleus. | Life Sci Alliance | 2024 | 38296350 | PubTator, text mining | PubMed |
| Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer. | Cancer Immunol Immunother | 2024 | 38294569 | PubTator, text mining | PubMed |
| Pro-inflammatory cytokines stimulate CFTR-dependent anion secretion in pancreatic ductal epithelium. | Cell Mol Biol Lett | 2024 | 38262945 | PubTator, text mining | PubMed |
| Decongestion in Acute Heart Failure-Time to Rethink and Standardize Current Clinical Practice? | J Clin Med | 2024 | 38256444 | PubTator, text mining | PubMed |
| Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response. | Metabolites | 2024 | 38248854 | PubTator, text mining | PubMed |
| Development of UTX-143, a selective sodium-hydrogen exchange subtype 5 inhibitor, using amiloride as a lead compound. | Bioorg Med Chem | 2024 | 38246115 | PubTator, text mining | PubMed |
| cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment. | J Hematol Oncol | 2024 | 38233872 | PubTator, text mining | PubMed |
| Hexamethylene amiloride synergizes with venetoclax to induce lysosome-dependent cell death in acute myeloid leukemia. | iScience | 2024 | 38205254 | PubTator, text mining | PubMed |
| The Underlying Rab Network of MRGPRX2-Stimulated Secretion Unveils the Impact of Receptor Trafficking on Secretory Granule Biogenesis and Secretion. | Cells | 2024 | 38201297 | PubTator, text mining | PubMed |
| Ion Transport and Inhibitor Binding by Human NHE1: Insights from Molecular Dynamics Simulations and Free Energy Calculations. | J Phys Chem B | 2024 | 38185879 | PubTator, text mining | PubMed |
| Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes. | Basic Res Cardiol | 2024 | 38170280 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity. | Int J Biol Sci | 2024 | 38164177 | PubTator, text mining | PubMed |
| Identification of two novel heterodimeric ABC transporters in melanoma: ABCB5β/B6 and ABCB5β/B9. | J Biol Chem | 2024 | 38145744 | PubTator, text mining | PubMed |
| Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE/PKC/NOX axis. | Redox Biol | 2024 | 38061206 | PubTator, text mining | PubMed |
| Na+ /H+ exchanger NHE1 is active at cell-cell contacts and facilitates cell dissemination during collective migration of melanoma cells. | Exp Dermatol | 2024 | 38009253 | PubTator, text mining | PubMed |
| Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation. | J Biol Chem | 2024 | 37992803 | PubTator, text mining | PubMed |
| Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors. | Adv Ther | 2024 | 37943443 | PubTator, text mining | PubMed |
| Salt and Aldosterone - Reciprocal and Combined Effects in Preclinical Models and Humans. | Horm Metab Res | 2024 | 37683690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=7